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Tuesday, April 20, 2021
During this COVID-19 pandemic and other future events, the CDM has been
and will continue to be a source of reliable information, education and models
for mitigation, preparedness, response, and recovery. We hope this
informational document has helped provide you filtered and actionable
information. As the pace of new information and changes occur, we will
evaluate the current once per week to determine if this information should be
provided on a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Recovered

Total Tested

Worldwide

142,112,632

3,030,299

81,325,274

Not Available

United States

31,738,228

567,694

Not Available

417,360,348

New Jersey

981,036

25,161

Not Available

13,034,835

New York

2,003,938

51,627

Not Available

48,960,229

Connecticut

331,401

8,014

Not Available

7,697,168

Information as of 4/20/21 at 0000 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
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Collaborated with NYMC medical students and on April 6, 2021, presented at NYMC Medical
Student Research Seminar regarding “Drawing Parallels between Public Health Crises and
COVID-19”
Delivered Geriatric Emergency Medical Services (GEMS) course to members of different
public safety agencies from New York.
Presented invited lecture regarding COVID-19 response and best practices to graduate
students enrolled in Master in Homeland Security degree in Guatemala.
Coordinating and overseeing COVID-19 screenings at NYMC campus
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.

To view the Center for Disaster Medicine's newest webinar, please click here - The
COVID-19 Vaccine: What to Tell Your Patients

Federal
•

The White House released a report on the potential for inflation with respect to the COVID19 pandemic and how it will impact daily living. The report noted, “in the next several months
we expect measured inflation to increase somewhat, primarily due to three different
temporary factors: base effects, supply chain disruptions, and pent-up demand, especially
for services. We expect these three factors will likely be transitory, and that their impact
should fade over time as the economy recovers from the pandemic. After that, the longerterm trajectory of inflation is in large part a function of inflationary expectations. Here, too, we
see some increase, but from historically low to more normal levels.”
https://www.whitehouse.gov/briefing-room/blog/2021/04/12/pandemic-prices-assessinginflation-in-the-months-and-years-ahead/

The White House
As part of President Biden’s continued efforts to ensure the pandemic response reaches all
people and all communities, the Biden Administration announced it will invest more than $4
billion to combat COVID-19 in Indian Country.
https://www.whitehouse.gov/briefing-room/statements-releases/2021/04/16/fact-sheet-bidenadministration-invests-4-billion-in-american-rescue-plan-funding-to-combat-covid-19-in-indiancountry/
The official website of the White House delivers bold action and immediate relief for American
families as the country grapples with converging crises. This includes actions to control the
COVID-19 pandemic, provide economic relief, tackle climate change, and advance racial equity
and civil rights, as well as immediate actions to reform our immigration system and restore
America’s standing in the world.
https://www.whitehouse.gov

Health and Human Services (HHS)
The U.S. Department of Health and Human Services (HHS) announced the availability of nearly
$150 million to community-based health care providers to aid their response to COVID-19.
These funds will support approximately 100 Health Center Program look-alikes to respond to
and mitigate the spread of COVID-19, strengthen vaccination efforts, and enhance health care
services and infrastructure in communities across the country. Health center look-alikes (LALs)
are community-based health care providers that provide essential primary care services to
underserved communities and vulnerable populations but are not Health Center Program
grantees. This funding will be made available through the Health Resources and Services
Administration (HRSA) and is part of President Biden's commitment to ensuring equity in the
nation's COVID-19 response and vaccination efforts.
https://www.hhs.gov/about/news/2021/04/19/hhs-announces-nearly-150-million-dollars-fromamerican-rescue-plan.html
On April 16, COVID-19 Health Equity Chair, Marcella Nunez-Smith, M.D.,convened the second
COVID-19 Health Equity Task Force to discuss the Biden-Harris Administration’s whole-ofsociety approach to mitigate the health inequities caused or exacerbated by the COVID-19
pandemic and for preventing such inequities in the future. This meeting specifically covered
vaccine access and confidence.
https://www.hhs.gov/about/news/2021/04/13/readout-second-covid-19-health-equity-task-forcemeeting.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)

The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3
clinical trial to test several existing prescription and over-the-counter medications for people to
self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID‑19 Therapeutic
Interventions and Vaccines (ACTIV) public–private partnership, the ACTIV-6 trial aims to provide
evidence-based treatment options for the majority of adult patients with COVID-19 who have
mild-to-moderate symptoms and are not sick enough to be hospitalized. NIH will provide an
initial investment of $155 million in funding for the trial.
https://www.nih.gov/news-events/news-releases/large-clinical-trial-study-repurposed-drugs-treatcovid-19-symptoms
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease
damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study
from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19.
MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already
approved by the U.S. Food and Drug Administration for use against COVID-19, must be
provided intravenously, making its use primarily limited to clinical settings.
https://www.nih.gov/news-events/news-releases/experimental-antiviral-covid-19-effectivehamster-study
The National Institutes of Health is awarding up to $33 million over two years to fund projects at
10 institutions across eight states to build evidence on safely returning students, teachers and
support staff to in-person school in areas with vulnerable and underserved populations. This
funding was made available by the American Rescue Plan. Known as the Safe Return to School
Diagnostic Testing Initiative, the awards are part of the NIH Rapid Acceleration of Diagnostics
Underserved Populations (RADx-UP) program, which aims to increase COVID-19 testing access
and uptake for vulnerable and underserved populations. Projects will combine frequent COVID19 testing with proven safety measures to reduce the spread of the SARS-CoV-2 virus.
https://www.nih.gov/news-events/news-releases/nih-funded-covid-19-testing-initiative-aimssafely-return-children-person-school
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of
Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial
(ACTT-4) has closed to enrollment because the study met pre-defined futility criteria indicating
that neither treatment regimen studied is likely significantly better than the other. The NIAIDsponsored trial aimed to determine which of two drug combinations—baricitinib plus remdesivir
or dexamethasone plus remdesivir — was more effective at preventing adults hospitalized with
COVID-19 on supplemental oxygen from progressing to requiring mechanical ventilation or
death, among other outcomes.
https://www.nih.gov/news-events/news-releases/nih-closes-enrollment-trial-comparing-covid-19treatment-regimens
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
As of April 16, 2021, 363 tests and sample collection devices are authorized by the FDA
under emergency use authorizations (EUAs). These include 266 molecular tests and
sample collection devices, 75 antibody and other immune response tests, and 22 antigen
tests. There are 46 molecular authorizations and one antibody authorization that can be
used with home-collected samples. There is one molecular prescription at-home test, two
antigen prescription at-home tests, four over-the-counter (OTC) at-home antigen tests,
and two OTC molecular tests. The FDA has authorized 7 antigen tests and 2 molecular
tests for serial screening programs. The FDA has also authorized 457 revisions to EUA
authorizations.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-updateapril-16-2021
The U.S. Food and Drug Administration revoked the emergency use authorization (EUA)
that allowed for the investigational monoclonal antibody therapy bamlanivimab, when
administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults
and certain pediatric patients. Based on its ongoing analysis of emerging scientific data,
specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to
bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has
determined that the known and potential benefits of bamlanivimab, when administered
alone, no longer outweigh the known and potential risks for its authorized use. Therefore,
the agency determined that the criteria for issuance of an authorization are no longer met
and has revoked the EUA.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdarevokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Centers for Disease Control and Prevention (CDC)
COVID-19 vaccines are effective. However, a small percentage of people who are fully
vaccinated will still get COVID-19 if they are exposed to the virus that causes it. These
are called “vaccine breakthrough cases.” This means that while people who have been
vaccinated are much less likely to get sick, it may still happen. Experts continue to study
how common these cases are.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/why-measureeffectiveness/breakthrough-cases.html
The emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are significant to
public health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.

https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

Center for Medicare and Medicaid Services (CMS)
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of April 20, 2021, the FDA has granted Emergency Use
Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson. Now
with three vaccines with EUA, the goal is to vaccinate a larger number of persons in the
coming months throughout the United States. As additional vaccines are granted EUA,
information for those vaccines will also be included. CDC provides update on “How to talk
about COVID-19 vaccines with friends and family.” COVID-19 vaccines are new, and it’s
normal to for people to have questions about them. The sheer amount of information—
and misinformation—about COVID-19 vaccines can be overwhelming to anyone.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/talk-about-vaccines.html
CDC created this section regarding COVID-19 vaccinations in the United States. CDC
provides overall U.S. COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m.. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
Effective April 19, 2021, CDC announced that everyone 16 years of age and older is now
eligible to get a COVID-19 vaccination. Get a COVID-19 vaccine as soon as you can.
Widespread vaccination is a critical tool to help stop the pandemic.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/How-Do-I-Get-a-COVID-19Vaccine.htmlA joint media briefing with the U.S. Centers for Disease Control and
Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a
rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.
https://www.cdc.gov/media/releases/2021/a0413-jj-vaccine.html
On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson &
Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far
in the United States, a small number of reports of a rare and severe type of blood clot
have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine. All
reports occurred among women between the ages of 18 and 48, and symptoms occurred

six to 13 days after vaccination. As of April 13, 2021, of the more than 180 million doses
administered so far of the Pfizer-BioNTech or Moderna vaccines, no reports matching
those associated with the J&J/Janssen vaccine have been received.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
On April 19, 2021, Governor Andrew M. Cuomo updated New Yorkers on the state's
vaccination program. 131,589 doses have been administered across the state's vast
distribution network in the last 24 hours, and nearly 1.4 million doses have been
administered over the past seven days.
https://www.governor.ny.gov/news/governor-cuomo-updates-new-yorkers-statevaccination-program-39
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
NYS DOH releases instructions for New York State-operated vaccination sites
https://covid19vaccine.health.ny.gov/
NYC DOHMH provides 2021 Health Alert #6 regarding Cases of Cerebral Venous Sinus
Thrombosis with Thrombocytopenia after receipt of the Johnson & Johnson COVID-19
Vaccine
https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2021/covid-19-jj-vaccinecvst.pdf
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page

The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
•

•

Higher Education
o A bill allowing students to record class sessions for the purpose of
lodging free speech and other complaints is likely to become law in
Florida. The bill, which sailed through Florida’s House of Representatives
and Senate, says that a student may record video or audio of class
lectures not only for their own personal educational use but also “in
connection with a complaint to the public institution of higher education
where the recording was made, or as evidence in, or in preparation for, a
criminal or civil proceeding.” A recorded lecture may not be published
without the consent of the lecturer, and these recordings must follow
federal student privacy laws, the bill says. The possible penalty for
publishing a recording without consent is $200,000.
https://www.insidehighered.com/news/2021/04/16/florida-poised-passbill-allowing-students-record-classes
K-12
o Kindergarten students, who did not enroll or attend schooling in
noticeable numbers during the pandemic, are expected to have larger
participation rates next school year, and school systems are planning
now to meet these young learners' needs. In fact, some education
experts are predicting a “kindergarten bubble” of 4-, 5- and 6-year-olds
who may be more unprepared for formal schooling compared to past
years’ cohorts, and who will come to school with a wider range of skills
based on their COVID-19 academic and social experiences.Typically,
preschool and kindergarten are filled with hands-on, play-based activities
that not only support early reading and math skills, but also introduce vital
social and emotional skills such as sharing, turn-taking and resolving
conflicts, according to early childhood education experts. But when the
pandemic forced those experiences online unnaturally, many families
decided to delay enrollment or attendance in formal schooling. In
fact, preschool and kindergarten enrollment dipped by sizable numbers in
some places. https://www.k12dive.com/news/prepare-now-for-predictedinflux-of-kindergarteners/598224/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates
New York
•

•

Governor Andrew M. Cuomo announced that spectators will be allowed at horse and
auto races at 20 percent capacity, beginning Thursday, April 22. Spectators will be
subject to the State's strict guidance, which is currently in effect for other professional
sports competitions with fans. Attendees must show proof of a recent negative test or
completed vaccination series prior to entry and are subject to the State's health and
safety protocols on face coverings, social distancing, and health screening. The
Governor also announced that the curfew for food and beverage establishments will be
moved from 11 p.m. to midnight effective Monday, April 19. The curfew for catered
events will move from midnight to 1 a.m. https://www.governor.ny.gov/news/governorcuomo-announces-spectators-will-be-allowed-horse-and-auto-races-20-percent-capacity
Governor Cuomo announced that applications are now being accepted for the $26.6
million available to support essential workers and first responders through the Empire
Pandemic Response Reimbursement Fund program. The program, coordinated by the
New York State Office of Children and Family Services, is designed to reimburse out-ofpocket child or dependent care, transportation, lodging and other qualifying expenses
that eligible workers incurred while employed in New York State between March 1, 2020,
through the date of application submission. Up to $1,000 is available per household. The
funding comes from private donations from individuals, charitable trusts and
businesses made during the COVID crisis. https://www.governor.ny.gov/news/governorcuomo-announces-applications-now-being-accepted-266-million-empire-pandemic-grant

New York State Department of Health (DOH)
For a list of positive cases by county in New York State
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH

https://coronavirus.health.ny.gov/home

New Jersey
•

•

Governor Phil Murphy signed into law A-5445, which provides $10 million in federal
COVID-19 relief aid for childcare providers throughout New Jersey. The bill – sponsored
by Senators M. Teresa Ruiz and Joseph Lagana and Assembly Members Lisa Swain,
Gabriela Mosquera, and Adam Taliaferro – will provide grants to childcare providers in
need. The bill is part of a five-bill, $100 million relief effort aimed at helping New Jersey’s
economy recover from the year-long
pandemic. https://www.nj.gov/governor/news/news/562021/approved/20210413b.shtml
Governor Murphy signed Executive Order No. 235. The Order extends the Public Health
Emergency that was declared on March 9, 2020 through Executive Order No. 103,
which was previously extended in 2020 on April 7, May 6, June 4, July 2, August
1, August 27, September 25, October 24, November 22, and December 21, and again in
2021 on January 19, February 17, and March 17. Under the Emergency Health Powers
Act, a declared public health emergency expires after 30 days unless renewed.
https://nj.gov/infobank/eo/056murphy/pdf/EO-235.pdf

Connecticut
•

Governor Ned Lamont, along with Lt. Governor Susan Bysiewicz and Consumer
Protection Commissioner Michelle Seagull, announced that the Connecticut Department
of Consumer Protection (DCP) has published a step-by-step informational guide to
pursuing a career in the skilled trades that aims to promote a more diverse workforce,
and support women and historically disadvantaged groups in finding stable employment
and higher wages as Connecticut recovers from the economic downturn of the COVID19 pandemic. https://portal.ct.gov/careerinthetrades

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page

Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of April 18, 2021
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d

For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus

Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of April 16, 2021https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of April 19, 2021
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of April 19, 2021
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
April 19, 2021
https://rockland-covid-19-portal-rockland.hub.arcgis.com/
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/

Healthcare
The House passed legislation (H.R. 1868) last week to extend the moratorium on the two percent
across-the-board Medicare payment cuts—also known as Medicare sequestration cuts—to all
providers that serve Medicare patients through the end of 2021. President Joe Biden signed it into
law shortly thereafter.
https://www.gnyha.org/news/president-biden-signs-bill-extending-moratorium-on-2-payment-cuts-tomedicare-providers/
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Center for Disaster Medicine Media
New York Medical College Leadership News:
NYMC disaster response center awarded $1M from state
The Business Journal
4/14/2021
https://westfaironline.com/135149/nymc-disaster-response-center-awarded-1m-from-state/
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
New York Medical College Center of Excellence in Precision Responses to Bioterrorism
and Disasters Awarded $1 Million In State Funding
River Journal
4/14/2021
https://riverjournalonline.com/schools/new-york-medical-college-center-of-excellence-inprecision-responses-to-bioterrorism-and-disasters-awarded-1-million-in-state-funding/23851/
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
David S. Markenson, M.D., M.B.A., medical director of the Center for Disaster Medicine
Johnson & Johnson vaccine paused: What this means for New York
Spectrum News
4/13/2021

https://spectrumnews1.com/oh/cincinnati/politics/2021/04/13/johnson---johnson-paused--what-this-means-for-ny
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president for government affairs
New York Medical College News:
New York Medical College awarded state funding for bioterrorism response
Mid-Hudson News
4/14/2021
https://midhudsonnews.com/2021/04/14/new-york-medical-college-awarded-state-funding-forbioterrorism-respone/

Every effort is made to provide accurate and complete information in this newsletter. However, New
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of
this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the
advice of your physician or other qualified health provider with any questions you may have regarding a
medical condition.

New York Medical College
Center for Disaster Medicine
7 Dana Road Suite 511
Valhalla, New York 10595
914-594-1750

https://www.nymc.edu/center-for-disaster-medicine/

